PREVPAC-1

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

64 Suppliers, 23 USDMF, 19 CEP/COS, 16 JDMF, 6 EU WC, 61 KDMF, 13 NDC API, 35 Listed Suppliers

DEVELOPMENTS

20 Drug(s) in Development

20 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

456 Dossiers, 50 FDA Orange Book, 198 Europe, 26 Canada, 9 Australia, 37 South Africa, 136 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 125MG/5ML, FOR SUSPENSION;ORAL - 250MG/5ML, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 34 Kerry, 28 BASF, 25 Roquette, 16 Seppic, 15 Microlex e.U, 14 Corel Pharma Chem, 13 Gangwal Chemicals, 12 Sigachi Industries, 12 Ideal Cures Pvt Ltd, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Nanjing Well Pharmaceutical, 10 Gangwal Healthcare, 9 SPI Pharma, 9 Actylis, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Lonza Capsugel, 6 DFE Pharma, 5 Prachin Chemical, 4 Pharmatrans-Sanaq, 4 Vasa Pharmachem, 4 Ingredion Pharma Solutions, 3 Jai Radhe Sales, 3 DKSH, 3 Rochem International Inc, 3 Nanjing Bold Chemical, 3 Boai NKY Pharmaceuticals Ltd, 3 Kima Chemical, 2 Clariant, 2 Alcedo Pharmachem, 2 Nomisma Healthcare, 2 Ulanqab Kema New Material, 2 Seqens, 2 Finar, 2 The Dow Chemical Company, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 NEWEDGE Overseas, 1 Pharm-RX Chemical, 1 ACG Worldwide, 1 Evonik, 1 Chynops Pharma, 1 Qualicaps, 1 Pfanstiehl, 1 Lubrizol Life Science Health, 1 Minakem, 1 Vertellus, 1 Avesta Pharma, 1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

72 Coating Systems & Additives, 71 Fillers, Diluents & Binders, 42 Controlled & Modified Release, 35 Solubilizers, 34 Disintegrants & Superdisintegrants, 32 Direct Compression, 31 Thickeners and Stabilizers, 26 Lubricants & Glidants, 25 Granulation, 25 Topical, 21 Parenteral, 19 Film Formers & Plasticizers, 15 Taste Masking, 14 Co-Processed Excipients, 11 Emulsifying Agents, 11 Chewable & Orodispersible Aids, 8 API Stability Enhancers, 7 Surfactant & Foaming Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 175 Finished Drug Prices

MARKET PLACE

35 APIs, 14 DOSSIERS // FDF

PATENTS

57 Health Canada Patents

57 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 7 USP Standards, 10 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 27 News

Information, Expiry & Status of Health Canada Patents covering PREVPAC-1.

PREVPAC-1

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

64 Suppliers

23 USDMF

19 CEP/COS

16 JDMF

6 EU WC

61 KDMF

13 NDC API

35 Listed Suppliers

DEVELOPMENTS

20 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

456 Dossiers

50 FDA Orange Book

198 Europe

26 Canada

9 Australia

37 South Africa

136 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION;ORAL - 125MG/5ML

FOR SUSPENSION;ORAL - 250MG/5ML

CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

34 Kerry

28 BASF

25 Roquette

16 Seppic

15 Microlex e.U

14 Corel Pharma Chem

13 Gangwal Chemicals

12 Sigachi Industries

12 Ideal Cures Pvt Ltd

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Nanjing Well Pharmaceutical

10 Gangwal Healthcare

9 SPI Pharma

9 Actylis

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Lonza Capsugel

6 DFE Pharma

5 Prachin Chemical

4 Pharmatrans-Sanaq

4 Vasa Pharmachem

4 Ingredion Pharma Solutions

3 Jai Radhe Sales

3 DKSH

3 Rochem International Inc

3 Nanjing Bold Chemical

3 Boai NKY Pharmaceuticals Ltd

3 Kima Chemical

2 Clariant

2 Alcedo Pharmachem

2 Nomisma Healthcare

2 Ulanqab Kema New Material

2 Seqens

2 Finar

2 The Dow Chemical Company

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 NEWEDGE Overseas

1 Pharm-RX Chemical

1 ACG Worldwide

TABLET;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons